Work Productivity and Activity Impairment in Osteoarthritis Patients Receiving Etoricoxib versus Diclofenac: A Prospective Observational Study
Soeharso Orthopaedic Journal · 02.11.2026 · 1 (2) · 44-51
DOI: 10.65745/soj.v1.i2.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Soeharso Orthopaedic Journal, online erschienen am 02.11.2026. Verfasst von Adi Nurmesa. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteoarthritis (OA) is a common musculoskeletal condition that adversely affects work productivity and daily activities. This study aimed to assess the convergent validity and test–retest reliability of the Indonesian version of the Work Productivity and Activity Impairment Questionnaire for Osteoarthritis (WPAI-OA) and compare productivity-related outcomes between patients receiving etoricoxib and diclofenac sodium. A prospective observational study was conducted involving 30 outpatients with OA at three tertiary hospitals in Indonesia between January 2023 and March 2024. Participants completed the WPAI-OA and EQ-5D-5L questionnaires at baseline and one week later. Convergent validity was assessed using Spearman's correlation coefficients, while test–retest reliability was evaluated among clinically stable participants. The WPAI-OA demonstrated moderate to strong correlations with EQ-5D-5L scores (|r| = 0.570–0.694), supporting its convergent validity. Test–retest correlations across questionnaire domains ranged from 0.385 to 0.694. Patients receiving etoricoxib reported lower work time missed (4.80% vs. 7.59%) and overall work impairment (20.49% vs. 23.09%) than those receiving diclofenac sodium. These findings provide preliminary evidence supporting the convergent validity and reproducibility of the Indonesian WPAI-OA in patients with OA. Although differences in productivity outcomes were observed between treatment groups, the small sample size and observational design limit causal interpretation. Further studies with larger samples are warranted to confirm the instrument's measurement properties and explore treatment-related differences.
Zitieren
APA
Nurmesa, A. (2026). Work Productivity and Activity Impairment in Osteoarthritis Patients Receiving Etoricoxib versus Diclofenac: A Prospective Observational Study. Soeharso Orthopaedic Journal, 1(2), 44-51. https://doi.org/10.65745/soj.v1.i2.16
Vancouver
Nurmesa A. Work Productivity and Activity Impairment in Osteoarthritis Patients Receiving Etoricoxib versus Diclofenac: A Prospective Observational Study. Soeharso Orthopaedic Journal. 2026;1(2):44-51. doi:10.65745/soj.v1.i2.16
BibTeX
@article{Nurmesa2026,
author = {Nurmesa, Adi},
title = {Work Productivity and Activity Impairment in Osteoarthritis Patients Receiving Etoricoxib versus Diclofenac: A Prospective Observational Study},
journal = {Soeharso Orthopaedic Journal},
year = {2026},
volume = {1},
number = {2},
pages = {44--51},
doi = {10.65745/soj.v1.i2.16}
}
EUVIMED